FindTrial
Sign In

cells

OTHER9 trials

Sponsors

Shandong Provincial Hospital, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou Red Cross Hospital, Children's Hospital of Fudan University

Conditions

Breast CancerFetal congenital heart diseaseGastric cancerKidney TransplantationNeuroblastomaSilicosisatherosclerosislung cancer

Early Phase 1

Study on the Application of Peripheral Blood Circulating Tumor Cells in Early Diagnosis, Treatment and Prognostic Evaluation of Gastric Cancer
RecruitingChiCTR2000031049
The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation ArmyGastric cancer
Start: 2020-03-20Updated: 2020-03-23
Donor HLA genotyping by next generation sequencing of DNA from urine-derived cells of renal allograft recipients
RecruitingChiCTR2000033735
The First Affiliated Hospital of Sun Yat-sen UniversityKidney Transplantation
Start: 2018-06-01Updated: 2020-06-15
The consistency assessment between HER2 status of Circulating tumor cell and tissue biopsy, correlation analysis between inconsistent results and disease progression
RecruitingChiCTR2000035015
Guangzhou Red Cross HospitalBreast Cancer
Start: 2020-07-22Updated: 2020-08-03
Application of CD24+ circulating tumor cells in the metastasis and prognosis assessment of neuroblastoma in children
Active, not recruitingChiCTR2000036764
Children's Hospital of Fudan UniversityNeuroblastoma
Start: 2020-10-01Updated: 2020-09-21
Prospective, single-center observation study of tissue and blood consistency and dynamic changes of EGFR, KRAS, P53 gene mutation detection of lung cancer using a new liquid biopsy technology based on red blood cells
RecruitingChiCTR2100042604
Department of Thoracic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Scienceslung cancer
Start: 2021-03-01Updated: 2021-05-03

Phase 1

Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
CompletedNCT01977131
Wei YuSilicosis
Start: 2010-06-30End: 2013-09-30Updated: 2013-11-25

Unknown Phase

Profiling genomic biomarkers in airway cells in the Chinese population
RecruitingChiCTR-DPD-17011856
The Second Affiliated hospital of Zhejiang University School of Medicinelung lesion, lung cancer
Start: 2017-07-05Updated: 2017-07-10
Establishment and application of the technology system about capture of circular epithelial cells in peripheral blood, target gene expression and single cell sequencing
Active, not recruitingChiCTR1900024505
Shandong Provincial HospitalFetal congenital heart disease
Start: 2019-07-20Updated: 2019-07-15
Correlation between the expression of CFIm25 in peripheral blood mononuclear cells and coronary atherosclerosis
Active, not recruitingChiCTR2200061732
The Second Affiliated Hospital of Nanjing Medical Universityatherosclerosis
Start: 2022-07-15Updated: 2023-04-03

Related Papers

Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up
Genetics and Molecular Research2015-01-0131 citations